According to Vendrusculo et al., collagenases MMP-2 and -9, which degrade collagens and cleave ECM proteins, play a crucial role in joint destruction and the development of pain during RA progression, and therefore their inhibitors may represent a new therapeutic treatment of pain in patients with rheumatoid arthritis [91]. Here, MMP2 is linked to rheumatoid arthritis.